Access to The Global Fund FundingUpdate

September 2016Geneva, Switzerland

Funding Cycle

REVIEW

GRANT-MAKING

APPROVAL

FUNDIN

G APPLIC

ATIO

N

GRANT IMPLEMENTATION

ONGOING COUNTRY DIALOGUE

APPLICATION

PROCESS

TECH

NIC

AL C

OO

PERA

TIO

N A

ND

REP

ROGR

AMM

ING N

EEDED

NATIONAL STRATEGIES

PRO

GR

AM

REV

IEW APPLICATION PROCESS:

6-9 MONTHS

GRANT IMPLEMENTATION:3 YEARS

Differentiated application and review modalities: agreed with Strategy Committee

2

• Country components requiring material change in defined programmatic area(s); or• Country components receiving Transition Funding or otherwise using a transition work plan as basis for their funding

request; or• Challenging operating environments (COE) country components with material change; or• Innovative approaches, learning opportunities (NSP) or results - based financing modalities (RBF)

Tailored Review: tailored to the objective and to the applicant type

• Focused and Core country components with less than 2 years of implementation (High Impact considered on case - by - case basis ); or

• Focused and Core country components with demonstrated performance and no material change needed (High Impact considered on case -by - case basis); or

Note: To maximize impact against the diseases, program continuation components may in addition reprogram at any time (duringgrant-making or grant implementation) & OPN on reprogramming will apply.

Program continuation: streamlined process for program continuation

• High Impact country components• Focused and Core country components referred to full review • Country components not reviewed by the TRP in the previous allocation period

Full Review: comprehensive overall review of investment approach and strategic priorities

3

ProgramContinuation:a) Secretariat screeningb) CCM request (Feb)c) TRP validation(window 1 only)

Re-programming

NSP

COE

Transition

Innovativeapproaches

Full proposal TRP fullreview

Grant making

TRP tailoredreview

GAC+ Board

Implementation(reprogramming can berequested at any time)

Communication toolbox

• 2017 Eligibility List + Transition projections - published October

• Access to Funding Operational Policy Note - published October

• TORs and membership of TRP - published November

• Application materials - published December

• Information Notes - published December

• Allocation letters - sent December

• FAQ updates published as monthly digest: mid-Sept, mid-Oct, mid-Nov, mid-Dec

• New e-learning courses on: differentiated application process, sustainable transition,

human rights, key populations - January

• Applicant Guide using best practice examples - January

4

Webinars: Train the trainer sessions for GF partners• Each topic offered twice on the same day to allow for different time zones• Invites will be sent out two weeks in advance with confirmed topic

5

Draft schedule

18 + 26 October Differentiated application process: overview to funding cycle

25 October Co-financing for 2017 - 2019 cycle

1 November Updated CCM eligibility and country dialogue guidance

8 November Sustainable transition funding application expectations for transition applicants

15 November Human rights and gender equality in funding requests

22 November Resilient and sustainable systems for health in funding requests

29 November Challenging operating environments applicants

6 + 7 December Allocation key messages and catalytic investments operationalization

13 + 14 December Application materials and resources

17 January TRP review approach and review criteria

24 January Multi-country (Regionals)

Timeline: coming up next

6

September October November December January February March

Key events

Finance andStrategy

CommitteeMeetings

BoardMeeting

AllocationLetters Sent

Tentative: 1 st

SubmissionTentative: 1 st

TRP Meeting

Internalpreparation

QualitativeFactors

Application +ReviewStream

Approval

On-goingSupport toApplicants

ApplicationMaterialsPublished

Eligibility ListPublished

7

If no materialchange

If materialchange

1. Secretariat assessment;2. Applicant (CCM) assessment; Program continuationTRP

validation

Info for material change assessment : 1. Allocation and funding landscape2. Results / Performance3. Epidemiology contextual considerations4. Investing to maximize impact towards

ending the epidemics, noting scientific evidence or normative guidance, new technologies

5. Effectiveness of implementation approaches

6. Risk mitigation considerations7. Progress on TRP/GAC and Board

recommendations8. Ensuring RSSH and HRG9. Sustainability, Transition & Co -financing

Tailored review

Full review

1

2

3

Check-list: material change triggers for program continuation (1/2)

8

Allocation and funding landscape

Results and performance(programmatic and financial)

Risk considerations

Progress on TRP/GAC and Boardrecommendations

STC requirements (e.g. application focus,co-financing)

Assessment: material change triggers for program continuation (2/2)Relevance of strategic focus and technical soundness; and potential for impact in line with GF Strategy.

Epidemiological contextual updates

NSP revisions and updates

Investing to maximize impact towardsending the epidemics (noting choice of interventions,normative guidance, new technologies, etc.)

Effectiveness of implementation approaches

Funding landscape and STC

Ensuring RSSH & HRG in line with Strategy

Secretariat Assessment Applicant Assessment

TRP assesses the two sources of information and provides recommendations

High Impact or allocation > 400m (25 portfolios)

Focused: allocation < 75m (87 portfolios)

Core: allocation >75m < 400m (30 portfolios)

Portfolio Categorization

9

• Serbia• Solomon

Islands• Sri Lanka• Suriname• Tajikistan• Timor-Leste• Tunisia• Turkmenistan• Uzbekistan

• Angola

• Benin

• Burkina Faso

• Cameroon

• Congo

• Guatemala

• Lesotho

• Madagascar

• Namibia

• Nepal

• Papua New

Guinea

• Rwanda

• Senegal

• Swaziland

• Togo

• Bangladesh

• Cambodia

• Côte d'Ivoire

• Ethiopia

• Ghana

• India

• Indonesia

• Malawi

• Mozambique

• Myanmar

• Philippines

• South Africa

• Tanzania

• Thailand

• Uganda

• Viet Nam

• Zambia

• Zanzibar

• Zimbabwe

• QMU-M-

UNOPS (RAI)

• Albania• Algeria• Armenia• Azerbaijan• Belarus• Belize• Bhutan• Bolivia• Botswana• Bosnia and

Herzegovina• Bulgaria• Cape Verde• Colombia• Comoros• Costa Rica• Cuba• Djibouti

• Dominican Republic

• Ecuador• Egypt• El Salvador• Fiji• Gabon• Gambia• Georgia• Guyana• Honduras• Iran• Jamaica• Jordan• Kazakhstan• Korea, DPR• Kosovo• Kyrgyzstan

• Lao PDR• Macedonia

(FYR)• Malaysia• Mauritania• Mauritius• Moldova• Mongolia• Morocco• Nicaragua• Panama• Paraguay• Peru• Romania• Russian

Federation• Sao Tome and

Principe

• QMJ -C-UNDP• QMJ -M-UNDP• QMT-H-EHRN• QMZ-H-ECUO• QMZ-T-PAS• QPA -H-ANECCA• QPA -H-HIVOS• QPA -H-SADC• QPA -H-UNDP• QPA -M-E8S• QPA -T-ECSA• QPA -T-WHC• QPB -H-KANCO• QPF -H-ALCO• QRA -H-HIVOS• QRA -H-IOM• QSA -H-APN+• QSF -T-IOM

Multi/Regional

• Iraq• Palestine

• Syrian Arab Republic• Yemen • Congo, DR

• Kenya

• Nigeria

• Pakistan

• Sudan

• Afghanistan• Burundi• Central African

Republic• Chad• Eritrea• Guinea• Guinea -Bissau

• Haiti• Liberia• Mali• Niger• Sierra Leone• Somalia• South Sudan• Ukraine

COE

• MAR -H-SISCA• MAT -011 -G01 -H• MEA -011 -G01 -H• MEI -011 -G01 -H• MMM-011 -G01 -H• MSA -910-G02-H• QMG -M-PSI

Middle East Initiative

2017 -2019 Allocation methodology

10

ReplenishmentConference

Malaria(32%)

TB(18%)

HIV(50%)

Up to $800m

Up to $800m

Available sources of funds for allocation

Catalytic investments

Allocation formula using

disease burden and

country economic capacity

Formula derived

amounts

Transparent qualitative

adjustments

Communication of country

allocation with flexibility on

program split

Funding request +

application for catalytic investments

if eligible

ONGOING COUNTRY DIALOGUE

NATIONAL STRATEGIES

Eligibility for funding

11

• Eligibility is determined by a country’s income level and disease burden• The Global Fund Eligibility List identifies country components eligible to receive an allocation, however this does not

mean an allocation will be automatically awarded

Income level

Disease burden

Not eligible:• Upper-Middle income countries with low/moderate disease burden• G-20 Upper-Middle income countries with less than extreme disease burden• High income countries.

Low income countries

Lower -LMI countries

Upper-LMI countries Upper-Middle income countries

No restriction

No restriction

No restriction

Extreme, Severe or High

Extreme

This is a reprint of "Access to Funding" brochure by The Global Fund.

CONTACT LAC REGIONAL PLATFORMLatin America and the Caribbean Regional Platform for Support, Coordination and Communication of Civil Society and Communities

CRAT – VÍA LIBRE - International HIV/AIDS Alliance

Jirón Paraguay 490. Lima 1 – Peru.

www.plataformalac.org | facebook: www.facebook.com/plataformaLAC | Twitter: @plataformalac